By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company LifeMD, Inc.

LifeMD, Inc. (LFMD)

NASDAQ Currency in USD
$5.89
-$0.06
-1.01%
Last Update: 11 Sept 2025, 20:00
$279.29M
Market Cap
-27.93
P/E Ratio (TTM)
Forward Dividend Yield
$3.99 - $15.84
52 Week Range

LFMD Stock Price Chart

Explore LifeMD, Inc. interactive price chart. Choose custom timeframes to analyze LFMD price movements and trends.

LFMD Company Profile

Discover essential business fundamentals and corporate details for LifeMD, Inc. (LFMD) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

IPO Date

29 Jan 2008

Employees

304.00

CEO

Justin Schreiber

Description

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

LFMD Financial Timeline

Browse a chronological timeline of LifeMD, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 4 May 2026

Upcoming earnings on 6 Nov 2025

EPS estimate is -$0.06, while revenue estimate is $62.07M.

Earnings released on 5 Aug 2025

EPS came in at -$0.05 falling short of the estimated $0.18 by -125.96%, while revenue for the quarter reached $62.22M , missing expectations by -6.18%.

Earnings released on 6 May 2025

EPS came in at $0.01 surpassing the estimated -$0.04 by +125.00%, while revenue for the quarter reached $65.70M , beating expectations by +0.36%.

Earnings released on 10 Mar 2025

EPS came in at -$0.02 surpassing the estimated -$0.04 by +50.00%, while revenue for the quarter reached $64.25M , beating expectations by +7.77%.

Earnings released on 7 Nov 2024

EPS came in at -$0.14 falling short of the estimated -$0.10 by -40.00%, while revenue for the quarter reached $40.28M , missing expectations by -30.21%.

Earnings released on 7 Aug 2024

EPS came in at -$0.19 falling short of the estimated -$0.13 by -46.15%, while revenue for the quarter reached $50.66M , beating expectations by +5.00%.

Earnings released on 8 May 2024

EPS came in at -$0.19 falling short of the estimated -$0.13 by -46.15%, while revenue for the quarter reached $44.14M , beating expectations by +3.77%.

Earnings released on 11 Mar 2024

EPS came in at -$0.12 surpassing the estimated -$0.14 by +14.29%, while revenue for the quarter reached $44.86M , beating expectations by +10.79%.

Earnings released on 8 Nov 2023

EPS came in at -$0.20 falling short of the estimated -$0.18 by -11.11%, while revenue for the quarter reached $38.61M , missing expectations by -4.63%.

Earnings released on 9 Aug 2023

EPS came in at -$0.23 falling short of the estimated -$0.09 by -155.56%, while revenue for the quarter reached $35.95M , beating expectations by +2.24%.

Earnings released on 12 May 2023

EPS came in at -$0.15 surpassing the estimated -$0.16 by +6.25%, while revenue for the quarter reached $33.13M , beating expectations by +7.55%.

Earnings released on 22 Mar 2023

EPS came in at $0.02 surpassing the estimated -$0.18 by +111.11%, while revenue for the quarter reached $28.12M , missing expectations by -16.31%.

Earnings released on 10 Nov 2022

EPS came in at -$0.03 surpassing the estimated -$0.27 by +88.89%, while revenue for the quarter reached $31.41M , missing expectations by -1.36%.

Earnings released on 11 Aug 2022

EPS came in at -$0.22 surpassing the estimated -$0.23 by +4.35%, while revenue for the quarter reached $30.46M , missing expectations by -2.73%.

Earnings released on 13 May 2022

EPS came in at -$0.25 surpassing the estimated -$0.26 by +3.85%, while revenue for the quarter reached $29.04M , missing expectations by -7.88%.

Earnings released on 7 Mar 2022

EPS came in at -$0.29 surpassing the estimated -$0.39 by +25.64%, while revenue for the quarter reached $27.42M , missing expectations by -0.16%.

Earnings released on 10 Nov 2021

EPS came in at -$0.36 surpassing the estimated -$0.49 by +26.53%, while revenue for the quarter reached $24.95M , missing expectations by -20.97%.

Earnings released on 12 Aug 2021

EPS came in at -$0.51 falling short of the estimated -$0.45 by -13.33%, while revenue for the quarter reached $22.31M , beating expectations by +1.98%.

Earnings released on 13 May 2021

EPS came in at -$0.38 surpassing the estimated -$0.44 by +13.64%, while revenue for the quarter reached $18.20M , missing expectations by -22.99%.

Earnings released on 29 Mar 2021

EPS came in at -$2.56 falling short of the estimated -$0.27 by -848.15%, while revenue for the quarter reached $12.89M .

Earnings released on 16 Nov 2020

EPS came in at -$1.33 , while revenue for the quarter reached $11.01M .

Stock split effective on 14 Oct 2020

Shares were split 1 : 5 , changing the number of shares outstanding and the price per share accordingly.

LFMD Stock Performance

Access detailed LFMD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run